LifeMD, Inc.

NasdaqGM:LFMD Stock Report

Market Cap: US$234.7m

LifeMD Future Growth

Future criteria checks 2/6

LifeMD is forecast to grow earnings and revenue by 91.2% and 20.1% per annum respectively while EPS is expected to grow by 88.3% per annum.

Key information

91.2%

Earnings growth rate

88.3%

EPS growth rate

Healthcare Services earnings growth32.2%
Revenue growth rate20.1%
Future return on equityn/a
Analyst coverage

Good

Last updated23 Aug 2024

Recent future growth updates

Recent updates

It's Down 27% But LifeMD, Inc. (NASDAQ:LFMD) Could Be Riskier Than It Looks

Aug 16
It's Down 27% But LifeMD, Inc. (NASDAQ:LFMD) Could Be Riskier Than It Looks

LifeMD: High Growth GLP-1 Telehealth Play At A Discount

Jul 31

LifeMD: Pairing GLP-1 Agonists With Virtual Healthcare

Jun 11

LifeMD: Moving Towards Profitability

May 22

Is LifeMD (NASDAQ:LFMD) Using Debt Sensibly?

Apr 25
Is LifeMD (NASDAQ:LFMD) Using Debt Sensibly?

Even With A 29% Surge, Cautious Investors Are Not Rewarding LifeMD, Inc.'s (NASDAQ:LFMD) Performance Completely

Mar 30
Even With A 29% Surge, Cautious Investors Are Not Rewarding LifeMD, Inc.'s (NASDAQ:LFMD) Performance Completely

LifeMD: Results And Guidance Point To Continued Strength In Weight Management Program

Mar 13

LifeMD's 2024: Striking A Balance Between Rapid Expansion And Sustainability

Jan 22

LifeMD: A GLP-1 Play With A Kicker

Jan 11

Is LifeMD, Inc. (NASDAQ:LFMD) Potentially Undervalued?

Jan 05
Is LifeMD, Inc. (NASDAQ:LFMD) Potentially Undervalued?

Take Care Before Jumping Onto LifeMD, Inc. (NASDAQ:LFMD) Even Though It's 34% Cheaper

Jan 05
Take Care Before Jumping Onto LifeMD, Inc. (NASDAQ:LFMD) Even Though It's 34% Cheaper

Does This Valuation Of LifeMD, Inc. (NASDAQ:LFMD) Imply Investors Are Overpaying?

Dec 03
Does This Valuation Of LifeMD, Inc. (NASDAQ:LFMD) Imply Investors Are Overpaying?

Investors Still Aren't Entirely Convinced By LifeMD, Inc.'s (NASDAQ:LFMD) Revenues Despite 38% Price Jump

Apr 17
Investors Still Aren't Entirely Convinced By LifeMD, Inc.'s (NASDAQ:LFMD) Revenues Despite 38% Price Jump

Analysts Are Betting On LifeMD, Inc. (NASDAQ:LFMD) With A Big Upgrade This Week

Nov 17
Analysts Are Betting On LifeMD, Inc. (NASDAQ:LFMD) With A Big Upgrade This Week

LifeMD launches at-home screening kits for breast, colon cancers

Sep 14

LifeMD Non-GAAP EPS of -$0.22 beats by $0.01, revenue of $30.5M misses by $1.45M

Aug 11

LifeMD CEO Justin Schreiber - Disrupting Healthcare With Telemedicine

Jan 10

LifeMD: 4 Reasons You Should Avoid This Stock

Sep 29

LifeMD: Telehealth Growth Spectacular

Sep 17

Earnings and Revenue Growth Forecasts

NasdaqGM:LFMD - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026294-2N/AN/A4
12/31/2025255-213397
12/31/2024206-227237
6/30/2024178-27717N/A
3/31/2024164-26817N/A
12/31/2023153-2409N/A
9/30/2023136-32-71N/A
6/30/2023129-33-11-3N/A
3/31/2023123-39-26-17N/A
12/31/2022119-49-36-23N/A
9/30/2022118-55-39-27N/A
6/30/2022112-61-43-31N/A
3/31/2022104-64-42-32N/A
12/31/202193-62-36-33N/A
9/30/202178-75-36-34N/A
6/30/202164-85-32-31N/A
3/31/202151-73-22-22N/A
12/31/202037-63-13-12N/A
9/30/202028-32-6-5N/A
6/30/202020-9-1-1N/A
3/31/202014-500N/A
12/31/201912-300N/A
9/30/201911-300N/A
6/30/201910-300N/A
3/31/20199-3-10N/A
12/31/20188-2-1-1N/A
9/30/20186-2-1-1N/A
6/30/20186-2-1-1N/A
3/31/20185-1N/A0N/A
12/31/20174-1N/A-1N/A
9/30/20175-2N/A-1N/A
6/30/20173-1N/A-1N/A
3/31/20174-2N/A-1N/A
12/31/20165-1N/A0N/A
9/30/20165-1N/A0N/A
6/30/201640N/A0N/A
3/31/201630N/A0N/A
12/31/201510N/A0N/A
9/30/201510N/A0N/A
6/30/201510N/A0N/A
3/31/201510N/A0N/A
12/31/201410N/A0N/A
9/30/201410N/A0N/A
6/30/201410N/A0N/A
3/31/201410N/A0N/A
12/31/201310N/A0N/A
9/30/201310N/A0N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: LFMD is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: LFMD is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: LFMD is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: LFMD's revenue (20.1% per year) is forecast to grow faster than the US market (8.8% per year).

High Growth Revenue: LFMD's revenue (20.1% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if LFMD's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y